Dyne Therapeutics DYN
NASDAQ DYN
$17.99 +0.07 (+0.39%)
As of: Nov 11, 2026 · 3:59 PM EST

Dyne Therapeutics (DYN) Return on Equity [ROE] (2020 - 2026)

Updated

Dyne Therapeutics (DYN) reported Return on Equity [ROE] of -64.72% for Q2 2026, up 1.44 percentage points from -66.16% a year earlier but down 16.55 percentage points from the prior quarter.

Analysis

Dyne Therapeutics (DYN) Return on Equity [ROE] (2020 - 2026) Analysis & Trends

For FY2025, Dyne Therapeutics posted Return on Equity [ROE] of -54.72%, up 33.18 percentage points from FY2024.

  • Return on Equity [ROE] has a five-year change of -21.84 percentage points (FY2020 to FY2025).
  • By year, Return on Equity [ROE] came in at -87.91% in FY2024 (+48.58 pp), -136.49% in FY2023 (-82.33 pp), -54.16% in FY2022 (-12.14 pp) and -42.02% in FY2021 (-9.14 pp).
  • Five-year quarterly Return on Equity [ROE] spans a low of -192.76% in Q4 2023 and a high of -29.09% in Q3 2021.
  • Year over year, Return on Equity [ROE] gained in five of the last eight quarters, with an average year-over-year change of +25.84 percentage points.
  • The high point for year-over-year Return on Equity [ROE] in five years was Q4 2024 (a gain of 145.30 percentage points); the low point was Q4 2023 (a drop of 125.82 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -48.18% (Q1 2026), -53.05% (Q4 2025) and -66.87% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 74.39%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 19.33%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 5.63%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 21.60%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 72.13%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -31.17%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 4.66%
10 Dyne Therapeutics 3.36 Bn -757.60 Mn - -74.27%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -74.27%
Jun 30, 2026 -66.36%
Mar 31, 2026 -49.21%
Dec 31, 2025 -53.58%
Sep 30, 2025 -67.10%
Jun 30, 2025 -66.49%
Mar 31, 2025 -56.48%
Dec 31, 2024 -47.54%
Sep 30, 2024 -39.71%
Jun 30, 2024 -41.14%
Mar 31, 2024 -90.39%
Dec 31, 2023 -193.45%
Sep 30, 2023 -115.43%
Jun 30, 2023 -83.87%
Mar 31, 2023 -71.20%
Dec 31, 2022 -67.08%
Sep 30, 2022 -67.81%
Jun 30, 2022 -58.82%
Mar 31, 2022 -45.63%
Dec 31, 2021 -38.23%
API Access

Dyne Therapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=DYN&period=max&api_key=YOUR_API_KEY